
The Counterpoint Quantitative Equity ETF seeks long-term capital appreciation. The Fund invests in individual stocks that have exposure to multiple factors and are among the highest-ranking stocks to hold as determined by quantitative models and artificial intelligence to seek outperformance relative to the market.
Is CPAI's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

Counterpoint Mutual Funds LLC boosted its position in Counterpoint Quantitative Equity ETF (NYSEARCA:CPAI) by 5.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,300,416 shares of the company's stock after buying an additional 61,500 shares during the quarter. Counterpoint Quantitative

I initiate coverage of the Counterpoint Quantitative Equity ETF, an actively managed vehicle utilizing AI-driven models in the portfolio creation process, with a Hold rating. CPAI's performance since inception in 2023 has been impressive, as it has trounced IVV, QQQ, IJH, IJR, and AIEQ. However, its risk-adjusted returns have been rather weak owing to high volatility, plus downside capture was at 135.5%.

Counterpoint Quantitative Equity ETF holds 50 stocks selected by adaptive machine learning models. The CPAI ETF has outperformed the S&P MidCap 400 and S&P 500 since inception, showing resilience in the recent market downturn. Moreover, it has outperformed other AI-powered ETFs over the last 12 months, although one of them has a better Sharpe ratio.